Jarden Research Adjusts Telix Pharmaceuticals' Price Target to AU$16.62 From AU$13.94, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF), CSL (OtherCMXHF) and Telix Pharmaceuticals Ltd. (OtherTLPPF)
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
Jarden Research Adjusts AUB Group's Price Target to AU$33.35 From AU$33.85, Keeps at Overweight
Analysts Offer Insights on Healthcare Companies: Immutep Ltd (OtherPRRUF) and Redcare Pharmacy (GB:0RJT)
Telix Pharmaceuticals Ltd. (TLPPF) Gets a Buy From Wilsons
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
RBC Capital Markets Downgrades Sims to Underperform From Sector Perform, Price Target Is AU$10.75
Analysts Offer Insights on Financial Companies: BAWAG Group AG (DE:0B2), HSBC Holdings (GB:HSBA) and NIB Holdings Ltd (Frankfurt: DE:3GU)
Bell Potter Downgrades Telix Pharmaceuticals Ltd. (TLPPF) to a Hold
Bell Potter Downgrades Telix Pharmaceuticals to Hold From Buy, Price Target Is AU$14.50
Canaccord Starts Immutep at Buy, Price Target Is AU$1.00
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
Wilsons Sticks to Its Buy Rating for Immutep Ltd (PRRUF)
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 From AU$13.27, Keeps at Buy
Immutep Ltd (PRRUF) Gets a Buy From Bell Potter
UBS Upgrades Sims to Buy From Neutral; Price Target Is AU$14.50
Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Telix Pharmaceuticals Ltd. (TLPPF)